AlertWatch
AlertWatch

Tag

// ICU
AUG
19
2013

AlertWatch Granted Second Patent for OR Patient Monitoring System, Begins ICU Testing

FOR IMMEDIATE RELEASE ⎯ August 19, 2013, Ann Arbor, Michigan ⎯ AlertWatch, Inc.’s patient monitoring system just received patent #8,454,507 from the U.S. Patent and Trademark Office. The software system supports the delivery of patient care by providing an intuitive patient
BY
COMMENT 0
TAG , , ,
 Copyright 2019 AlertWatch. All rights reserved.

AlertWatch:OR and AlertWatch:OB are FDA 510(k)-cleared for sale in the United States, and are intended for use by clinicians for secondary monitoring of patients . AlertWatch accomplishes this by aggregating data from a multitude of sources and displaying them at a central location. Once alerted, the clinician must refer to the primary monitoring device before making a clinical decision.

AlertWatch:ICU, AlertWatch:AC, and AlertWatch:PACU are pending FDA clearance and are currently only available for IRB-sponsored research. Some images and interfaces are enhanced for clarity.